A peptides amino-acid sequence, salt form, purity, aggregation, degradation products, residual solvents, and storage conditions can affect what a patient receives
%20while%20breastfeeding%3F)
Advice for Healthcare Professionals The MHRA Drug Safety Update provides the following key guidance for healthcare professionals: Semaglutide treatment may be very rarely associated with NAION, which can cause vision loss, typically in one eye NAION typically presents as sudden, painless vision loss described as blurring or cloudiness Privately prescribed semaglutide may not appear on a patients medical record if a patient presents with these symptoms, enquire about semaglutide use Patients reporting sudden loss of vision (including partial loss) should be urgently referred for specialist examination by an ophthalmologist Discontinue semaglutide treatment if NAION is confirmed Advise new patients, or existing patients during medication reviews, to urgently attend eye casualty or A&E if they experience sudden vision loss or rapidly worsening eyesight An alert advised healthcare professionals to be vigilant for further issues, including rare but serious side effects such as acute pancreatitis
In patients with existing mold sensitization and allergic asthma, ongoing mycotoxin exposure can trigger severe asthma attacks and worsen pulmonary function
Going to bed and waking up at the same time daily, including on weekends, can improve sleep quality
This action collectively suppresses the production of key pro-inflammatory cytokines (TNF-, IL-6, IL-1) and profibrotic mediators like TGF-1
I have confidence in their ability to assist me with this journey
